Propanc Biopharma, Inc.
For the period ended Jun 30, 2025. Filed Sep 29, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 29, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
The Company’s Board of Directors reviews and approves audit and permissible non-audit services performed by its independent registered public accounting firm, as well as the fees charged for such services. In its review of non-audit service and its appointment of Salberg & Company, P.A. as our independent registered public accounting firm, the Board considered whether the provision of such services is compatible with maintaining independence. All of the services provided, and fees charged by Salberg & Company, P.A. in fiscal years ended June 30, 2025 and 2024 were approved by the Board of Directors. The following table shows the fees for the fiscal years ended June 30, 2025 and 2024:
| 2025 · 2024 | ||||
|---|---|---|---|---|
| Audit Fees (1) | $66,500 | $64,500 | ||
| Audit Related Fees (2) | $32,700 | $5,700 | ||
| Tax Fees (3) | $ | - | $ | - |
| All Other Fees | $ | - | $ | - |
| Total | $99,200 | $70,200 | ||
| (1) | Audit fees - these fees relate to the audit of our annual consolidated financial statements and the review of our interim quarterly consolidated financial statements. |
| (2) | Audit related fees - these fees relate primarily to the auditors’ review of our registration statements and audit related consulting. |
| (3) | Tax fees - no fees of this sort were billed by Salberg & Company P.A., our principal accountant during 2025 and 2024 fiscal years. |
All Other Fees
We did not incur any other fees related to services rendered by our independent registered public accounting firm for the fiscal years ended June 30, 2025 and 2024.
The SEC requires that before our independent registered public accounting firm is engaged by us to render any auditing or permitted non-audit related service, the engagement be either: (i) approved by our audit committee or (ii) entered into pursuant to pre-approval policies and procedures established by the audit committee, provided that the policies and procedures are detailed as to the particular service, the audit committee is informed of each service, and such policies and procedures do not include delegation of the audit committee’s responsibilities to management.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.